United States

Onyx initiates phase III comparison trial in relapsed multiple myeloma

Friday, July 6, 2012 02:10 PM

Onyx Pharmaceuticals, a San Francisco-based global biopharmaceutical company, has begun enrollment in the ENDEAVOR trial, a phase III trial evaluating Kyprolis (proposed brand name for carfilzomib) in combination with dexamethasone, versus bortezomib (Velcade) with dexamethasone in patients with relapsed multiple myeloma.

More... »

Mytrus appoints Anthony Costello as CEO

Friday, July 6, 2012 01:33 PM

Mytrus, a San Francisco-based clinical technology and services company for medical and pharmaceutical research, has appointed Anthony J. Costello as CEO. He

More... »

FDA proposes unique device identification system for medical devices

Thursday, July 5, 2012 12:11 PM

In response to requirements in legislation that passed Congress with broad bipartisan support, the FDA has proposed that most medical devices distributed in the U.S. carry a unique device identifier, or UDI.

More... »

Renaissance acquires DPT Laboratories

Thursday, July 5, 2012 11:28 AM

Renaissance Acquisition Holdings, a pharmaceutical company formed in partnership with RoundTable Healthcare Partners, has acquired DPT Laboratories, a pharmaceutical contract development and manufacturing organization with facilities in Lakewood, N.J., and San Antonio, Texas.

More... »

Marshall Edwards changes name to MEI Pharma

Tuesday, July 3, 2012 11:31 AM

Marshall Edwards, a San Diego-based oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, had decided to change its name to MEI Pharma, and its common stock will begin trading under the new ticker symbol MEIP.

More... »

Natus completes acquisition of Nicolet neurodiagnostic business

Tuesday, July 3, 2012 10:32 AM

Natus Medical, a San Carlos, Calif.-based provider of healthcare products, has completed the acquisition of the Nicolet neurodiagnostic business from CareFusion for an approximate $58 million cash.

More... »

Catalyst stockholders approve SXC merger

Tuesday, July 3, 2012 09:55 AM

Stockholders attending a special meeting for Catalyst Health Solutions, a fast-growing national pharmacy benefit management (PBM) company, have approved, among other things, the proposal to adopt the previously disclosed agreement and plan of merger with SXC Health Solutions, a Lisle, Ill.-based provider of PBM services and healthcare information technology solutions.

More... »

PharMerica introduces $25M share purchase program

Tuesday, July 3, 2012 09:22 AM

The board of directors of PharMerica, a national provider of institutional pharmacy and hospital pharmacy management services, has authorized an increase in its existing share purchase program that will allow the company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.

More... »

Pernix Therapeutics to acquire Great Southern Laboratories

Tuesday, July 3, 2012 09:08 AM

Pernix Therapeutics Holdings, a specialty pharmaceutical company of The Woodlands, Texas, has entered into a definitive agreement to acquire Great Southern Laboratories, a privately-held pharmaceutical contract manufacturing company of Houston, Texas.

More... »

NanoViricides raises $5M in shelf offering

Monday, July 2, 2012 11:09 AM

NanoViricides, a West Haven, Conn.-based development stage company that creates special purpose nanomaterials for antiviral therapy, has raised $5 million drawing down on its previously announced universal registered shelf “Form S-3” offering. The registered shelf offering became effective on April 29, 2010, and continues to remain effective.

More... »